Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include

Antiproliferative effects, induction of apoptosis and cell cycle deregulation

N. Yoshimizu, Y. Otani, Y. Saikawa, T. Kubota, M. Yoshida, Toshiharu Furukawa, K. Kumai, Kaori Kameyama, M. Fujii, M. Yano, T. Sato, A. Ito, M. Kitajima

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Aim: To demonstrate the antitumour effects of nobiletin (5,6,7,8,3′,4′-hexamethoxyflavone), a citrus flavonoid extracted from Citrus depressa Hayata, on human gastric cancer cell lines TMK-1, MKN-45, MKN-74 and KATO-III. Materials and methods: 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay, the TdT-mediated dUTP biotin nick-end labelling (TUNEL) method and cell-cycle analysis revealed that nobiletin acted on these cells in several ways, namely by direct cytotoxicity, induction of apoptosis and modulation of cell cycle. The efficacy of combined treatment of nobiletin with a conventional anticancer drug, CDDP, was also examined. Treatment with nobiletin 24 h prior to CDDP administration showed a synergistic effect compared to the control. Conclusions: Although the effective dose and administration route of nobiletin require further investigation, our study represents a potential successful linking of this compound with the treatment of gastric cancer.

Original languageEnglish
Pages (from-to)95-101
Number of pages7
JournalAlimentary Pharmacology and Therapeutics, Supplement
Volume20
Issue number1
Publication statusPublished - 2004 Jul

Fingerprint

Citrus
Flavonoids
Stomach Neoplasms
Cell Cycle
Apoptosis
Neoplasms
Biotin
nobiletin
Cell Line
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include : Antiproliferative effects, induction of apoptosis and cell cycle deregulation. / Yoshimizu, N.; Otani, Y.; Saikawa, Y.; Kubota, T.; Yoshida, M.; Furukawa, Toshiharu; Kumai, K.; Kameyama, Kaori; Fujii, M.; Yano, M.; Sato, T.; Ito, A.; Kitajima, M.

In: Alimentary Pharmacology and Therapeutics, Supplement, Vol. 20, No. 1, 07.2004, p. 95-101.

Research output: Contribution to journalArticle

Yoshimizu, N. ; Otani, Y. ; Saikawa, Y. ; Kubota, T. ; Yoshida, M. ; Furukawa, Toshiharu ; Kumai, K. ; Kameyama, Kaori ; Fujii, M. ; Yano, M. ; Sato, T. ; Ito, A. ; Kitajima, M. / Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include : Antiproliferative effects, induction of apoptosis and cell cycle deregulation. In: Alimentary Pharmacology and Therapeutics, Supplement. 2004 ; Vol. 20, No. 1. pp. 95-101.
@article{c9e6f491f7f74f4380ea70c714add6e3,
title = "Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include: Antiproliferative effects, induction of apoptosis and cell cycle deregulation",
abstract = "Aim: To demonstrate the antitumour effects of nobiletin (5,6,7,8,3′,4′-hexamethoxyflavone), a citrus flavonoid extracted from Citrus depressa Hayata, on human gastric cancer cell lines TMK-1, MKN-45, MKN-74 and KATO-III. Materials and methods: 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay, the TdT-mediated dUTP biotin nick-end labelling (TUNEL) method and cell-cycle analysis revealed that nobiletin acted on these cells in several ways, namely by direct cytotoxicity, induction of apoptosis and modulation of cell cycle. The efficacy of combined treatment of nobiletin with a conventional anticancer drug, CDDP, was also examined. Treatment with nobiletin 24 h prior to CDDP administration showed a synergistic effect compared to the control. Conclusions: Although the effective dose and administration route of nobiletin require further investigation, our study represents a potential successful linking of this compound with the treatment of gastric cancer.",
author = "N. Yoshimizu and Y. Otani and Y. Saikawa and T. Kubota and M. Yoshida and Toshiharu Furukawa and K. Kumai and Kaori Kameyama and M. Fujii and M. Yano and T. Sato and A. Ito and M. Kitajima",
year = "2004",
month = "7",
language = "English",
volume = "20",
pages = "95--101",
journal = "Alimentary Pharmacology and Therapeutics, Supplement",
issn = "0953-0673",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Anti-tumour effects of nobiletin, a citrus flavonoid, on gastric cancer include

T2 - Antiproliferative effects, induction of apoptosis and cell cycle deregulation

AU - Yoshimizu, N.

AU - Otani, Y.

AU - Saikawa, Y.

AU - Kubota, T.

AU - Yoshida, M.

AU - Furukawa, Toshiharu

AU - Kumai, K.

AU - Kameyama, Kaori

AU - Fujii, M.

AU - Yano, M.

AU - Sato, T.

AU - Ito, A.

AU - Kitajima, M.

PY - 2004/7

Y1 - 2004/7

N2 - Aim: To demonstrate the antitumour effects of nobiletin (5,6,7,8,3′,4′-hexamethoxyflavone), a citrus flavonoid extracted from Citrus depressa Hayata, on human gastric cancer cell lines TMK-1, MKN-45, MKN-74 and KATO-III. Materials and methods: 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay, the TdT-mediated dUTP biotin nick-end labelling (TUNEL) method and cell-cycle analysis revealed that nobiletin acted on these cells in several ways, namely by direct cytotoxicity, induction of apoptosis and modulation of cell cycle. The efficacy of combined treatment of nobiletin with a conventional anticancer drug, CDDP, was also examined. Treatment with nobiletin 24 h prior to CDDP administration showed a synergistic effect compared to the control. Conclusions: Although the effective dose and administration route of nobiletin require further investigation, our study represents a potential successful linking of this compound with the treatment of gastric cancer.

AB - Aim: To demonstrate the antitumour effects of nobiletin (5,6,7,8,3′,4′-hexamethoxyflavone), a citrus flavonoid extracted from Citrus depressa Hayata, on human gastric cancer cell lines TMK-1, MKN-45, MKN-74 and KATO-III. Materials and methods: 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay, the TdT-mediated dUTP biotin nick-end labelling (TUNEL) method and cell-cycle analysis revealed that nobiletin acted on these cells in several ways, namely by direct cytotoxicity, induction of apoptosis and modulation of cell cycle. The efficacy of combined treatment of nobiletin with a conventional anticancer drug, CDDP, was also examined. Treatment with nobiletin 24 h prior to CDDP administration showed a synergistic effect compared to the control. Conclusions: Although the effective dose and administration route of nobiletin require further investigation, our study represents a potential successful linking of this compound with the treatment of gastric cancer.

UR - http://www.scopus.com/inward/record.url?scp=4344618973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344618973&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 95

EP - 101

JO - Alimentary Pharmacology and Therapeutics, Supplement

JF - Alimentary Pharmacology and Therapeutics, Supplement

SN - 0953-0673

IS - 1

ER -